COMMUNIQUÉS West-GlobeNewswire

Mesoblast to Host Analyst Call on Results of End-Stage Heart Failure Trial Being Presented at 2018 American Heart Association Scientific Sessions
09/11/2018
NEW YORK and MELBOURNE, Australia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO) (ASX:MSB) will host a webcast to discuss the results of the Phase 2b trial evaluating its allogeneic mesenchymal [...]
RadNet Reports Third Quarter Financial Results and Reaffirms Previously Announced 2018 Guidance Levels
09/11/2018
Total Net Revenue (“Revenue”) increased 6.4% to $242.1 million in the third quarter of 2018 from $227.6 million in the third quarter of 2017 Adjusted EBITDA (1) increased 5.5% to $38.1 million in the third quarter of [...]
NASH clinical trial presentation and continued revenue growth
09/11/2018
Key Highlights: Professor Arun Sanyal to present IMM-124E NASH clinical trial results at the Liver Meeting in San Francisco Travelan® on display at HealthEd Australian Travelan® sales continue to grow, with a Q1 CY19 [...]
AC Immune Shares Insights from Key Opinion Leader Meeting on Abeta Oligomers in Alzheimer's Disease (AD) and Other Misfolded Proteins in AD and Neurodegenerative Diseases
09/11/2018
Increasing evidence points to Abeta oligomers as the toxic species in AD, and likely linked to Tau pathology and neuroinflammation. Immunotherapies and small molecule anti-Tau therapeutics hold much promise in treating [...]
Rule 2.9 Announcement
09/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 9 November 2018 [...]
Bavarian Nordic Announces Interim Results for the First Nine Months of 2018
09/11/2018
COPENHAGEN, Denmark, November 9, 2018 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results in line with guidance for the first nine months of 2018 and business progress for the [...]
Nine-month interim report (Q3) 2018
09/11/2018
Better than expected performance continued in Q3 (unaudited) Financial results in Q3 were again better than expected and the full-year outlook has been updated accordingly. Execution of ALK’s growth strategy saw good [...]
DBV Technologies to Present Data Further Supporting the Use of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy at the 2018 ACAAI Meeting
09/11/2018
Montrouge, France, November 9, 2018 DBV Technologies to Present Data Further Supporting the Use of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy at the 2018 ACAAI Meeting Three abstracts on Viaskin [...]
DBV Technologies présentera des données soutenant l'utilisation de l'immunothérapie épicutanée pour le traitement de l'allergie à l'arachide à l'ACAAI 2018
09/11/2018
Montrouge, France, le 9 novembre (07h30 CEST), 2018 DBV Technologies présentera des données soutenant l'utilisation de l'immunothérapie épicutanée pour le traitement de l'allergie à l'arachide à l'ACAAI 2018 Trois [...]
ESPERITE (ESP) expects publication of Annual Report 2017 before 17 November 2018
09/11/2018
Amsterdam, The Netherlands - 09 November 2018 Esperite announces that the preparation of its Annual Report 2017 is nearly finalized and expects the publication of its Annual Report 2017 before 17 November 2018. About [...]
Alligator Bioscience and Aptevo Therapeutics Present New Preclinical Data for ALG.APV-527 at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting
09/11/2018
Data Show That ALG.APV-527 Selectively Activates and Enhances Tumor -directed T-cell and Natural Killer (NK) Cell Responses Targets 5T4 Cancer Antigen Present on Many Types of Solid Tumors LUND, Sweden and SEATTLE, Nov [...]
Intuitive Announces New General Manager in Korea
09/11/2018
SUNNYVALE, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq: ISRG), has named Austin Kim as Vice President and General Manager in Korea, where he will direct business strategy and operations [...]
OV - Update Regarding Participation at Investor Events in Q4 2018
09/11/2018
Investor news Hørsholm, Denmark and Cambridge, MA, US, November 5 th , 2018 - Oncology Venture A/S ("Oncology Venture") today provided an update regarding when members of its senior management team are scheduled to make [...]
Sarepta Therapeutics Announces Pricing of $500,000,000 Public Offering of Common Stock
09/11/2018
CAMBRIDGE, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a leader in precision genetic medicine for rare diseases, today announced that it has priced an underwritten public offering [...]
Viveve to Present at Stifel 2018 Healthcare Conference
08/11/2018
ENGLEWOOD, Colo., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive officer and [...]
Cidara Provides Corporate Update and Reports Third Quarter 2018 Financial Results
08/11/2018
SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial results for the three [...]
ADMA Biologics Reports Third Quarter 2018 Financial Results
08/11/2018
RAMSEY, N.J. and BOCA RATON, Fla., Nov. 08, 2018 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the “Company”), a vertically integrated commercial biopharmaceutical company that develops, [...]
Innovation Pharmaceuticals Provides Corporate Update Highlighting Business Development and Clinical Pipeline Priorities
08/11/2018
BEVERLY, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide a corporate update highlighting business [...]
Radient Technologies Inc. Announces AGM Results and Completion of Shares for Debt Transaction
08/11/2018
EDMONTON, Alberta, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) ( TSX Venture: RTI ) today announces that all resolutions were passed by the requisite majority at its annual [...]

Pages